150 likes | 176 Views
The global 3D bioprinting market size reached US$ 1,032 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,621 Million by 2028, exhibiting a growth rate (CAGR) of 16.4% during 2023-2028...Read More: https://www.imarcgroup.com/3d-bioprinting-market
E N D
Global 3D Bioprinting Market Research Report 2023-2028 Author: Elena Anderson Marketing Manager IMARC Group © 2022 IMARC All Rights Reserved Copyright © IMARC Service Pvt Ltd. All Rights Reserved
About IMARC Group Report Description International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Global 3D Bioprinting MarketOutlook 2023-2028 : According to the latest report by IMARC Group, titled "3D Bioprinting Market:Global Industry Trends, Size, Share, Growth, Opportunity, and Forecast 2023-2028,“offers a comprehensive analysis of the industry, which comprises insights on the Global 3D Bioprinting Market. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global 3D bioprinting market reached a value of US$ 1,032 Million in 2022. The market value is expected to grow at US$ 2,621 Million by 2028, exhibiting a CAGR of 16.4% during the forecast period (2023-2028).3D bioprinting refers to the medical application of 3D printers for fabricating biological tissues and organs through the layering of living cells. It creates spatially-controlled patterns in 3D where viability and cell function are conserved within the printed construct. 3D bioprinting utilizes a layer-by-layer method to deposit materials like bio-inks. Bio-inks are obtained from living cells, biomaterials, and active biomolecules to create the 3D structure of tissues and organs. The technology offers speedy and accurate drug testing as potential drug compounds can be tested on bio-printed tissue before being used in human trials. It is also used to build complex bodily structures, including bones, skin, vascular grafts, tracheal splints, heart tissues, and cartilages. As a result, 3D bioprinting finds applications in the research and development of drugs, scaffolds, and medical implants. Request a Free PDF Sample of the Report: https://www.imarcgroup.com/3d-bioprinting-market/requestsample
Report Description and Highlights Report Description Global 3D Bioprinting Market Trends: The market is primarily driven by the increasing geriatric population and rising instances of respiratory and cardiovascular diseases that require organ transplants. The limited number of organ donors is propelling the demand for 3D bioprinting across healthcare organizations. In addition to this, the technology is used in cosmetic surgeries and the pharmaceutical industry, further supplementing the market growth. This has also resulted in growing public and private fundings, which have prompted market players to improve and strengthen their manufacturing and distribution capabilities. As a result, 3D bioprinting is used to create simple tissue structures in a lab setting; however, it can also build complete organs for transplants in the future, owing to technological advancements and the manufacturing of customized products. Moreover, manufacturers have introduced organ-on-a-chip and bio-printed structures that enable a 3D in-vitro analysis of bodily functions and aids in developing artificial organs and tissues. Furthermore, extensive R&D investments and increasing stem cell research have increased awareness regarding 3D bioprinting, which is positively influencing the market growth. View Report TOC, Figures and Tables: https://www.imarcgroup.com/3d-bioprinting-market
Report Description and Highlights Report Description • Key Market Segmentation: • The report has segmented the Global 3D Bioprinting Market on the basis of type, component, deployment mode, organization size and vertical. • Component Insights: • 3D Bioprinters • Syringe/Extrusion Bioprinting • Inkjet Bioprinting • Magnetic Levitation Bioprinting • Laser-assisted Bioprinting • Others • Scaffolds • Biomaterials • Living Cells • Hydrogels • Extracellular Matrices • Others
Report Description and Highlights Report Description • Application Insights: • Research • Drug Research • Regenerative Medicine • 3D Cell Culture • Clinical • Skin • Bone and Cartilage • Blood Vessels • Others • End User Insights: • Hospitals • Research Organization and Academic Institutes • Biopharmaceuticals Companies
Report Description and Highlights Report Description • Regional Insights: • North America • Asia-Pacific • Europe • Latin America • Middle East and Africa • Ask Analyst for Customization and Explore full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=4556&flag=E
Report Description and Highlights • Competitive Landscape With Key Players: • The competitive landscape Global 3D Bioprinting Market has been studied in the report with the detailed profiles of the key players operating in the market. • 3D Systems Inc. • Aspect Biosystems Ltd. • Cellink • Cyfuse Biomedical K.K. • EnvisionTEC GmbH (Desktop Metal Inc.) • GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH • Materialise • Organovo Holdings Inc. • Poietis • RegenHU • Stratasys Ltd. Report Description
Key Questions Answered in the Report Report Description • What was the size of the global 3D bioprinting market in 2022? • What is the expected growth rate of the global 3D bioprinting market during 2023-2028? • What are the key factors driving the global 3D bioprinting market? • What has been the impact of COVID-19 on the global 3D bioprinting market? • What is the breakup of the global 3D bioprinting market based on the component? • What is the breakup of the global 3D bioprinting market based on the application? • What is the breakup of the global 3D bioprinting market based on the end user? • What are the key regions in the global 3D bioprinting market? • Who are the key players/companies in the global 3D bioprinting market?
Table of Contents Report Description • Preface • Scope and Methodology • Executive Summary • Introduction • Global 3D Bioprinting Market • Market Breakup by Component • Market Breakup by Application • Market Breakup by End User • Market Breakup by Region • SWOT Analysis
Table of Contents Report Description • Value Chain Analysis • Porters Five Forces Analysis • Price Analysis • Competitive Landscape • Click Here to Visit the Complete Table of Content With List of Figures and Tables: https://www.imarcgroup.com/3d-bioprinting-market/toc
Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients
Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients
Report Description and Highlights Report Description © 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: • TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com